138 related articles for article (PubMed ID: 37563665)
1. Organisational models supported by technology for the management of diabetic disease and its complications in a diabetic clinic setting: study protocol for a randomised controlled trial targeting type 2 diabetes individuals with non-ideal glycaemic values (Telemechron study).
Giovanazzi A; Gios L; Mastellaro M; Gentilini MA; Valent F; Condini S; Bincoletto G; Bacchiega A; Zorzi A; Malfatti G; Perini F; Eccher C; Marchesoni M; Dall'Alda M; Orrasch M; Conforti D; Inchiostro S
Trials; 2023 Aug; 24(1):513. PubMed ID: 37563665
[TBL] [Abstract][Full Text] [Related]
2. Supporting Parents & Kids Through Lockdown Experiences (SPARKLE): A digital parenting support app implemented in an ongoing general population cohort study during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial.
Kostyrka-Allchorne K; Creswell C; Byford S; Day C; Goldsmith K; Koch M; Gutierrez WM; Palmer M; Raw J; Robertson O; Shearer J; Shum A; Slovak P; Waite P; Sonuga-Barke EJS
Trials; 2021 Apr; 22(1):267. PubMed ID: 33838678
[TBL] [Abstract][Full Text] [Related]
3. Rethinking Models of Outpatient Specialist Care in Type 2 Diabetes Using eHealth: Study Protocol for a Pilot Randomised Controlled Trial.
Menon A; Fatehi F; Bird D; Darssan D; Karunanithi M; Russell A; Gray L
Int J Environ Res Public Health; 2019 Mar; 16(6):. PubMed ID: 30889802
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a smartphone application for helping individuals with type 2 diabetes mellitus manage their blood glucose: a protocol for factorial design trial.
Tang H; Qin H; Zhang M; Zhang J; Tan H; Chen M; Kong L; Guo M; Hu F; Wang Q; Wang X; Zhang K; Xiong Z
Trials; 2023 Jul; 24(1):468. PubMed ID: 37480092
[TBL] [Abstract][Full Text] [Related]
6. Qatar Diabetes Mobile Application Trial (QDMAT): an open-label randomised controlled trial to examine the impact of using a mobile application to improve diabetes care in type 2 diabetes mellitus-a study protocol.
Suleiman N; Alkasem M; Al Amer Z; Salameh O; Al-Thani N; Hamad MK; Baagar K; Abdalhakam I; Othman M; Dughmosh R; Al-Mohanadi D; Al Sanousi A; Bashir M; Chagoury O; Taheri S; Abou-Samra AB
Trials; 2022 Jun; 23(1):504. PubMed ID: 35710428
[TBL] [Abstract][Full Text] [Related]
7. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
8. An automated structured education intervention based on a smartphone app in Chinese patients with type 1 diabetes: a protocol for a single-blinded randomized controlled trial.
Huang F; Wu X; Xie Y; Liu F; Li J; Li X; Zhou Z
Trials; 2020 Nov; 21(1):944. PubMed ID: 33225982
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of diabetes self-management education via a smartphone application in insulin treated type 2 diabetes patients - design of a randomised controlled trial ('TRIGGER study').
Boels AM; Rutten G; Zuithoff N; de Wit A; Vos R
BMC Endocr Disord; 2018 Oct; 18(1):74. PubMed ID: 30348142
[TBL] [Abstract][Full Text] [Related]
10. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
[TBL] [Abstract][Full Text] [Related]
11. BetaMe: impact of a comprehensive digital health programme on HbA1c and weight at 12 months for people with diabetes and pre-diabetes: study protocol for a randomised controlled trial.
Sarfati D; McLeod M; Stanley J; Signal V; Stairmand J; Krebs J; Dowell A; Leung W; Davies C; Grainger R
Trials; 2018 Mar; 19(1):161. PubMed ID: 29506562
[TBL] [Abstract][Full Text] [Related]
12. Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation - the CASCADE study.
Christie D; Thompson R; Sawtell M; Allen E; Cairns J; Smith F; Jamieson E; Hargreaves K; Ingold A; Brooks L; Wiggins M; Oliver S; Jones R; Elbourne D; Santos A; Wong IC; O'Neill S; Strange V; Hindmarsh P; Annan F; Viner R
Health Technol Assess; 2014 Mar; 18(20):1-202. PubMed ID: 24690402
[TBL] [Abstract][Full Text] [Related]
13. Smart Phone APP to Restore Optimal Weight (SPAROW): protocol for a randomised controlled trial for women with recent gestational diabetes.
Lim K; Chi C; Chan SY; Lim SL; Ang SM; Yoong JS; Tsai C; Wong SR; Yew TW; Tai ES; Yong EL
BMC Public Health; 2019 Oct; 19(1):1287. PubMed ID: 31615456
[TBL] [Abstract][Full Text] [Related]
14. Development of an information system and mobile application for the care of type 2 diabetes patients at the primary care level for the health sector in Mexico: study protocol for a randomized controlled, open-label trial.
Barengo NC; Apolinar LM; Estrada Cruz NA; Fernández Garate JE; Correa González RA; Diaz Valencia PA; Gonzalez CAC; Rodriguez JAG; González NC;
Trials; 2022 Apr; 23(1):253. PubMed ID: 35379298
[TBL] [Abstract][Full Text] [Related]
15. Supporting people with type 2 diabetes in effective use of their medicine through mobile health technology integrated with clinical care (SuMMiT-D Feasibility): a randomised feasibility trial protocol.
Farmer A; Allen J; Bartlett K; Bower P; Chi Y; French D; Gudgin B; Holmes EA; Horne R; Hughes DA; Kenning C; Locock L; McSharry J; Miles L; Newhouse N; Rea R; Riga E; Tarassenko L; Velardo C; Williams N; Williams V; Yu LM;
BMJ Open; 2019 Dec; 9(12):e033504. PubMed ID: 31888938
[TBL] [Abstract][Full Text] [Related]
16. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
17. A randomized wait-list control trial to evaluate the impact of a mobile application to improve self-management of individuals with type 2 diabetes: a study protocol.
Desveaux L; Agarwal P; Shaw J; Hensel JM; Mukerji G; Onabajo N; Marani H; Jamieson T; Bhattacharyya O; Martin D; Mamdani M; Jeffs L; Wodchis WP; Ivers NM; Bhatia RS
BMC Med Inform Decis Mak; 2016 Nov; 16(1):144. PubMed ID: 27842539
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the effectiveness and utility of a novel culturally-adapted telemonitoring system in improving the glycaemic control of Asians with type-2 diabetes mellitus: a mixed method study protocol.
Goh KLS; Lee CS; Koh CHG; Ling NL; Ang SB; Oh C; Lin Y; Yuan W; Zheng QC; Tan NC
Trials; 2021 Apr; 22(1):305. PubMed ID: 33902656
[TBL] [Abstract][Full Text] [Related]
19. Mobile Exergaming for Health-Effects of a serious game application for smartphones on physical activity and exercise adherence in type 2 diabetes mellitus-study protocol for a randomized controlled trial.
Höchsmann C; Walz SP; Schäfer J; Holopainen J; Hanssen H; Schmidt-Trucksäss A
Trials; 2017 Mar; 18(1):103. PubMed ID: 28264717
[TBL] [Abstract][Full Text] [Related]
20. Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.
Hemmingsen B; Gimenez-Perez G; Mauricio D; Roqué I Figuls M; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD003054. PubMed ID: 29205264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
